Literature DB >> 15764678

Ischemic preconditioning, insulin, and morphine all cause hexokinase redistribution.

Coert J Zuurbier1, Otto Eerbeek, Alfred J Meijer.   

Abstract

Association of hexokinase (HK) with mitochondria preserves mitochondrial integrity and is an important mechanism by which cancer cells are protected against hypoxic conditions. Maintenance of mitochondrial integrity also figures prominently as a major characteristic of many cardioprotective manipulations. In this study, we provide evidence that cardioprotective interventions may promote HK redistribution from the cytosol to the mitochondria in the heart. Isolated Langendorff-perfused rat hearts (n = 6/group) were subjected to normoxic perfusion (control, Con), three 5-min ischemia-reperfusion periods (ischemic preconditioning, IPC), 1 U/l insulin (Ins), or 1 microM morphine (Mor). Hearts were immediately homogenized and centrifuged to obtain whole cell, cytosolic, and mitochondrial fractions. HK, lactate dehydrogenase (LDH), and citrate synthase (CS) enzyme activities were determined. No change in LDH or CS present in the cytosol fraction relative to whole cell activity was observed with any of the cardioprotective interventions. By contrast, HK present in the cytosol fraction relative to whole cell activity decreased significantly (P < 0.05) with all cardioprotective interventions, from 0.58 +/- 0.03 (Con) to 0.46 +/- 0.04 (IPC), 0.41 +/- 0.01 (Ins), and 0.45 +/- 0.02 (Mor). In addition, HK relative to CS activity in the mitochondrial fraction increased significantly with cardioprotection, from 0.15 +/- 0.001 (Con) to 0.21 +/- 0.002 (IPC), 0.18 +/- 0.003 (Ins), and 0.21 +/- 0.005 (Mor). Our novel data suggest that well-known cardioprotective interventions share a common end-effector mechanism of cytosolic HK translocation. Association of HK with mitochondria may promote inhibition of the mitochondrial permeability transition pore and thereby reduce cell death and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15764678     DOI: 10.1152/ajpheart.01182.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  35 in total

Review 1.  What can we learn about cardioprotection from the cardiac mitochondrial proteome?

Authors:  Marjan Gucek; Elizabeth Murphy
Journal:  Cardiovasc Res       Date:  2010-08-30       Impact factor: 10.787

2.  Reduction in hexokinase II levels results in decreased cardiac function and altered remodeling after ischemia/reperfusion injury.

Authors:  Rongxue Wu; Kirsten M Smeele; Eugene Wyatt; Yoshihiko Ichikawa; Otto Eerbeek; Lin Sun; Kusum Chawla; Markus W Hollmann; Varun Nagpal; Sami Heikkinen; Markku Laakso; Kentaro Jujo; J Andrew Wasserstrom; Coert J Zuurbier; Hossein Ardehali
Journal:  Circ Res       Date:  2010-11-11       Impact factor: 17.367

Review 3.  Nuclear and mitochondrial signalling Akts in cardiomyocytes.

Authors:  Shigeki Miyamoto; Marta Rubio; Mark A Sussman
Journal:  Cardiovasc Res       Date:  2009-03-11       Impact factor: 10.787

Review 4.  Effect of hyperglycaemia and diabetes on acute myocardial ischaemia-reperfusion injury and cardioprotection by ischaemic conditioning protocols.

Authors:  Claudia Penna; Ioanna Andreadou; Manuela Aragno; Christophe Beauloye; Luc Bertrand; Antigone Lazou; Ines Falcão-Pires; Robert Bell; Coert J Zuurbier; Pasquale Pagliaro; Derek J Hausenloy
Journal:  Br J Pharmacol       Date:  2020-03-09       Impact factor: 8.739

5.  Hexokinase cellular trafficking in ischemia-reperfusion and ischemic preconditioning is altered in type I diabetic heart.

Authors:  Ebru Gurel; Savas Ustunova; Aysegul Kapucu; Nadim Yilmazer; Otto Eerbeek; Rianne Nederlof; Markus W Hollmann; Cihan Demirci-Tansel; Coert J Zuurbier
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

Review 6.  Hexokinases and cardioprotection.

Authors:  Guillaume Calmettes; Bernard Ribalet; Scott John; Paavo Korge; Peipei Ping; James N Weiss
Journal:  J Mol Cell Cardiol       Date:  2014-09-26       Impact factor: 5.000

7.  Pathophysiological consequences of TAT-HKII peptide administration are independent of impaired vascular function and ensuing ischemia.

Authors:  Rianne Nederlof; Chaoqin Xie; Otto Eerbeek; Anneke Koeman; Dan M J Milstein; Markus W Hollmann; Egbert G Mik; Alice Warley; Richard Southworth; Fadi G Akar; Coert J Zuurbier
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

Review 8.  Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection.

Authors:  D Morin; R Assaly; S Paradis; A Berdeaux
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

9.  Partial hexokinase II knockout results in acute ischemia-reperfusion damage in skeletal muscle of male, but not female, mice.

Authors:  Kirsten M Smeele; Otto Eerbeek; Anneke Koeman; Rick Bezemer; Can Ince; Sami Heikkinen; Markku Laakso; Arnold de Haan; Gert Schaart; Maarten R Drost; Markus W Hollmann; Coert J Zuurbier
Journal:  Pflugers Arch       Date:  2010-02-25       Impact factor: 3.657

Review 10.  Cardioprotection by metabolic shut-down and gradual wake-up.

Authors:  Lindsay S Burwell; Sergiy M Nadtochiy; Paul S Brookes
Journal:  J Mol Cell Cardiol       Date:  2009-03-10       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.